Xeris Pharmaceuticals announced on 2/11/19 that it filed a registration statement with the Securities and Exchange Commission (the “SEC”) relating to a proposed public offering of 5,000,000 shares... read more
Xeris Pharmaceuticals announced on 2/11/19 that it filed a registration statement with the Securities and Exchange Commission (the “SEC”) relating to a proposed public offering of 5,000,000 shares... read more
Seattle Genetics (Nasdaq:SGEN) announced on 2/11/19 that its collaborator, Takeda Pharmaceutical Company Limited, received approval from the European Commission to extend the marketing... read more
Shockwave Medical filed for its IPO on 2/8/19. While the filing did not list the number of shares to be offered or the expected offering price, the offering will bring in an expected maximum of $... read more
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced on 2/8/19 that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation... read more
HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, launched today with $60.75M in Series A funding led by ARCH Venture Partners.... read more